Please login or sign up to post and edit reviews.
As U.S. Drug Company Draws Scrutiny, Connecticut Activists Seek To Raise Awareness About HIV/AIDS
Podcast |
Where We Live
Media Type |
audio
Categories Via RSS |
Government
News
Society & Culture
Publication Date |
May 20, 2019
Episode Duration |
00:49:29

Gilead, the biopharmaceutical company responsible for manufacturing Truvada, has come under scrutiny for its HIV drug pricing. This hour, we get the latest on this story. We also preview an upcoming Hartford rally, scheduled to coincide with AIDS Awareness Day.

Plus, for various reasons, a couple might decide to have their embryos frozen. But what happens to those embryos after the couple divorces? We learn about a state Supreme Court case, which centers on this very issue.

And finally, the SAT has a new score. An adversity score, to be more specific. We find out what this means and check in on Connecticut’s SAT requirements.

Support the show: http://wnpr.org/donate

See omnystudio.com/listener for privacy information.

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review